tiragolumab

Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo
BioSpace
Mon, 07/8/24 - 11:41 am
Roche
clinical trials
tiragolumab
non-small cell lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Roche racks up phase 3 TIGIT win, but trial design leaves doubts
Fierce Biotech
Wed, 01/17/24 - 09:33 am
Roche
Tigit
immuno-oncology
tiragolumab
clinical trials
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Roche
Tigit
clinical trials
lung cancer
non-small cell lung cancer
tiragolumab
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
Roche keeps the faith in new cancer immunotherapy despite trial setbacks
BioPharma Dive
Tue, 06/7/22 - 10:30 am
Roche
tiragolumab
lung cancer
clinical trials
ASCO 2022
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
Roche believes cancer drug setback not a fatal blow to growth prospects
Reuters
Thu, 05/12/22 - 10:57 pm
Roche
drug development
tiragolumab
Strike 2: Roche flunks another phase 3 lung cancer test to leave TIGIT space reeling
Fierce Biotech
Wed, 05/11/22 - 10:38 am
Roche
tiragolumab
anti-TIGIT
non-small cell lung cancer
clinical trials
Roche's closely watched immunotherapy fails key study in tough-to-treat lung cancer
BioPharma Dive
Wed, 03/30/22 - 10:54 am
Roche
tiragolumab
clinical trials
Tigit
advanced small cell lung cancer
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
A year of TIGIT (and Alzheimer’s) for Roche
EP Vantage
Thu, 02/3/22 - 10:53 am
Roche
Tigit
tiragolumab
Alzheimer's disease
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
lung cancer
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Wed, 01/6/21 - 10:37 am
Roche
FDA
tiragolumab
Tecentriq
non-small cell lung cancer
breakthrough therapies
Roche’s TIGIT drug shows promise in untreated lung cancer
Pharmaforum
Fri, 05/15/20 - 10:56 am
Roche
ASCO 2020
tiragolumab
Tecentriq
metastatic non-small cell lung cancer
ASCO 2020 – first-line lung cancer focus
EP Vantage
Thu, 05/14/20 - 12:02 pm
Roche
Merck
Bristol-Myers Squibb
ASCO 2020
lung cancer
Keytruda
tiragolumab
Opdivo
Yervoy
Roche move endorses Iteos’s Tigit widget
EP Vantage
Tue, 03/3/20 - 10:52 am
Roche
Tigit
tiragolumab
Arcus Biosciences
iTeos Therapeutics